Cancer Biology Research in Connecticut
Cancer Biology Research (93.396) awarded $73.8 million to recipients in Connecticut in 51 grants from fiscal 2021 to 2025, 1.7% of the program's national total. Yale Univ received the most, $65.1 million.
- Awarded in Connecticut$73.8 million
- Awards51
- Share of the program1.7%
- Rank among states15th of 50
- National total$4.3 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 34 | $17.6 million |
| FY 2022 | 33 | $16.2 million |
| FY 2023 | 28 | $14.9 million |
| FY 2024 | 29 | $14.0 million |
| FY 2025 | 20 | $11.1 million |
Recipients in Connecticut
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Yale Univ | Colleges and universities | 43 | $65.1 million |
| University of Connecticut Health Center | Colleges and universities | 4 | $6.0 million |
| Atlasxomics Inc | Small businesses | 2 | $2.1 million |
| Cloverleaf Bio, Inc. | Small businesses | 1 | $399,966 |
| University of Connecticut Health Center | Colleges and universities | 1 | $163,982 |
Open opportunities under this program
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much Cancer Biology Research money goes to Connecticut?
$73.8 million from fiscal 2021 to 2025, across 51 awards. Connecticut ranks 15th of 50 states and territories for this program.
Who receives Cancer Biology Research money in Connecticut?
The largest recipient is Yale Univ, with $65.1 million in 43 awards. Next are University of Connecticut Health Center and Atlasxomics Inc.
Can organizations in Connecticut apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Biology Research in other states
Other large programs in Connecticut
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Temporary Assistance for Needy Families
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- USAID Foreign Assistance for Programs Overseas
- Special Education Grants to States
- Title I Grants to Local Educational Agencies